000 01398 a2200421 4500
005 20250511195453.0
264 0 _c19910819
008 199108s 0 0 eng d
022 _a0006-4971
040 _aNLM
_beng
_cNLM
100 1 _aBowden, R A
245 0 0 _aUse of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant.
_h[electronic resource]
260 _bBlood
_cJul 1991
300 _a246-50 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aBlood Platelets
_xphysiology
650 0 4 _aBone Marrow Transplantation
_xadverse effects
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCytomegalovirus
_xisolation & purification
650 0 4 _aCytomegalovirus Infections
_xblood
650 0 4 _aErythrocytes
_xmicrobiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLeukocyte Count
650 0 4 _aLeukocytes
_xphysiology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
700 1 _aSlichter, S J
700 1 _aSayers, M H
700 1 _aMori, M
700 1 _aCays, M J
700 1 _aMeyers, J D
773 0 _tBlood
_gvol. 78
_gno. 1
_gp. 246-50
999 _c1655453
_d1655453